Medicare Enrolled
Dr. Jayasree Rao, M.D.
Medical Oncology · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rao?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rao
Dr. Jayasree Rao is a medical oncology specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rao performed 204,265 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rao received a total of $15,672 from 88 pharmaceutical and/or device companies across 864 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rao is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 3% volume in TX
$15,672 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗204,265
Medicare services
Top 3% in TX for medical oncology
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim-ayow biosimilar injection, 1 microgram An injection of the biosimilar medication filgrastim-ayow (Releuko) at a dose of 1 microgram. |
69,120 | $0 | $3 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
33,120 | $0 | $1 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
28,800 | $0 | $1 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
15,900 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 12,360 | $18 | $47 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
8,340 | $6 | $16 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
7,793 | $0 | $1 |
| Anti-nausea injection (ondansetron/Zofran) | 6,455 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,220 | $6 | $15 |
| Panzyga immune globulin injection, 500 mg An intravenous injection of Panzyga, a non-lyophilized liquid immune globulin product, administered in a 500 mg dose. |
2,390 | $52 | $193 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
2,301 | $22 | $56 |
| Iron infusion (Monoferric) | 2,200 | $17 | $43 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,187 | $93 | $249 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
1,220 | $36 | $91 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
990 | $11 | $27 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
851 | $48 | $123 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
648 | $1 | $2 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
613 | $1 | $2 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
580 | $100 | $252 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
458 | $16 | $40 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
424 | $15 | $38 |
| Injection, calcium gluconate (fresenius kabi), per 10 mg | 377 | $0 | $1 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
368 | $0 | $1 |
| Iron dextran injection, 50 mg An injection containing 50 mg of iron dextran administered to the patient. |
358 | $13 | $34 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
316 | $131 | $349 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
280 | $69 | $176 |
| Injection, potassium chloride, per 2 meq | 280 | $0 | $1 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
241 | $12 | $30 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
240 | $1 | $3 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
214 | $50 | $124 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
214 | $0 | $2 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
212 | $22 | $54 |
| Intravenous immune globulin injection, 500 mg An injection of immune globulin administered into a vein to provide antibodies. The dose specified is 500 mg of non-lyophilized (liquid) immune globulin. |
209 | $449 | $1,789 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
183 | $1 | $4 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
182 | $24 | $63 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
131 | $4 | $9 |
| New patient office visit, complex (60-74 min) | 110 | $162 | $428 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
84 | $10 | $25 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
82 | $17 | $49 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
82 | $66 | $187 |
| Vancomycin injection, 500 mg A 500 mg dose of vancomycin antibiotic is administered via injection. |
36 | $2 | $6 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
28 | $29 | $72 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
27 | $4 | $11 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
23 | $8 | $17 |
| Calcium gluconate injection An injection of calcium gluconate administered in 10 ml increments. |
18 | $4 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.2% high complexity
93.9% medium
1.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,672
Total received (2018-2024)
Avg $2,239/year across 7 years
Top 33% in TX for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
864
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$908
2023
$3,772
2022
$2,668
2021
$2,364
2020
$555
2019
$2,520
2018
$2,886
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$682
Amneal Pharmaceuticals LLC
$82
Sumitomo Pharma America, Inc.
$25
ABBVIE INC.
$23
Tempus AI, Inc
$22
AstraZeneca Pharmaceuticals LP
$22
Daiichi Sankyo Inc.
$19
PFIZER INC.
$19
Amgen Inc.
$13
Top 3 companies account for 86.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,982
Janssen Biotech, Inc.
$1,189
E.R. Squibb & Sons, L.L.C.
$1,062
Genentech USA, Inc.
$691
AstraZeneca Pharmaceuticals LP
$581
Celgene Corporation
$580
GENZYME CORPORATION
$563
Amgen Inc.
$501
Eisai Inc.
$418
PFIZER INC.
$404
Merck Sharp & Dohme Corporation
$368
Boehringer Ingelheim Pharmaceuticals, Inc.
$345
Teva Pharmaceuticals USA, Inc.
$322
Puma Biotechnology, Inc.
$288
Daiichi Sankyo Inc.
$255
Bayer HealthCare Pharmaceuticals Inc.
$230
Takeda Pharmaceuticals U.S.A., Inc.
$224
Incyte Corporation
$223
Astellas Pharma US Inc
$190
Karyopharm Therapeutics Inc.
$186
Rigel Pharmaceuticals, Inc.
$182
Lilly USA, LLC
$176
Seagen Inc.
$171
Gilead Sciences, Inc.
$167
Ipsen Biopharmaceuticals, Inc
$165
EISAI INC.
$154
GlaxoSmithKline, LLC.
$147
Pharmacyclics LLC, An AbbVie Company
$138
Myriad Genetic Laboratories, Inc.
$137
Organon LLC
$136
Kite Pharma, Inc.
$130
PUMA BIOTECHNOLOGY, INC.
$127
Novo Nordisk Inc
$125
Taiho Oncology, Inc.
$119
Kyowa Kirin, Inc.
$119
ARRAY BIOPHARMA INC
$118
Helsinn Therapeutics (U.S.), Inc.
$117
JAZZ PHARMACEUTICALS INC.
$105
Amneal Pharmaceuticals LLC
$103
Merck Sharp & Dohme LLC
$100
TerSera Therapeutics LLC
$94
ABBVIE INC.
$92
Regeneron Healthcare Solutions, Inc.
$90
EMD Serono, Inc.
$89
AMAG Pharmaceuticals, Inc.
$85
Bayer Healthcare Pharmaceuticals Inc.
$83
SOBI, INC
$82
Seattle Genetics, Inc.
$81
ADC Therapeutics America, Inc.
$77
Foundation Medicine, Inc.
$74
Octapharma USA, Inc.
$73
AVEO Pharmaceuticals, Inc.
$72
Pharmacosmos Therapeutics Inc.
$72
Alexion Pharmaceuticals, Inc.
$69
MorphoSys, US Inc.
$69
BeiGene USA, Inc.
$68
Exelixis Inc.
$68
Dova Pharmaceuticals
$68
PharmaEssentia USA Corporation
$66
Sobi, Inc
$60
Sandoz Inc.
$54
CTI BioPharma Corp.
$52
AbbVie, Inc.
$46
Janssen Pharmaceuticals, Inc
$45
Deciphera Pharmaceuticals Inc.
$42
Mylan Institutional Inc.
$39
Adaptive Biotechnologies Corporation
$39
Spectrum Pharmaceuticals Inc.
$38
Verastem, Inc.
$38
SERVIER PHARMACEUTICALS LLC
$35
Aveo Pharmaceuticals, Inc.
$34
Clovis Oncology, Inc.
$33
R-Pharm US LLC
$25
Sumitomo Pharma America, Inc.
$25
Sun Pharmaceutical Industries Inc.
$24
Apellis Pharmaceuticals, Inc.
$23
NOVARTIS PHARMACEUTICALS CORPORATION
$23
TESARO, Inc.
$22
Tempus AI, Inc
$22
Agios Pharmaceuticals, Inc.
$20
Blueprint Medicines Corporation
$18
TAIHO ONCOLOGY, INC.
$17
Mirati Therapeutics, Inc.
$17
Tactile Systems Technology Inc
$14
Coherus Biosciences Inc.
$14
INSYS Therapeutics Inc
$14
Epizyme, Inc.,
$13
Lexicon Pharmaceuticals, Inc.
$13
Top 3 companies account for 27.0% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKYNZEO · ALIMTA · ALOXI · AVASTIN · AYVAKIT · Alecensa · Aliqopa · Aranesp · Avastin · BALVERSA · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · EVENITY · Empaveli · Enhertu · Erleada · FARESTON · FERAHEME · FOTIVDA · FOUNDATIONONE · Flexitouch Plus · Folotyn · Fulphila · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Ixempra · JADENU · JAKAFI · JARDIANCE · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Monoferric · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · ORGOVYX · Ogivri · Onivyde · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRADAXA · PRECISETUMOR · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · SYNDROS · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · Truxima · ULTOMIRIS · Udenyca · VENCLEXTA · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vonjo · Wegovy · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · YONSA · Yescarta · ZARXIO · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
37
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
BAPTIST MEDICAL CENTER
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rao is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rao experienced with filgrastim-ayow biosimilar injection, 1 microgram?
Based on Medicare claims data, Dr. Rao performed 69,120 filgrastim-ayow biosimilar injection, 1 microgram services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rao receive payments from pharmaceutical companies?
Yes. Dr. Rao received a total of $15,672 from 88 companies across 864 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rao's costs compare to other medical oncologists in San Antonio?
Dr. Rao's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in San Antonio
Browse medical oncologists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology